85 related articles for article (PubMed ID: 33785097)
1. Development of
Trujillo-Nolasco M; Cruz-Nova P; Ferro-Flores G; Gibbens-Bandala B; Morales-Avila E; Aranda-Lara L; Vargas M; Ocampo-García B
J Biomed Nanotechnol; 2021 Feb; 17(2):263-278. PubMed ID: 33785097
[TBL] [Abstract][Full Text] [Related]
2. Chemo-radiotherapy with
Cruz-Nova P; Gibbens-Bandala B; Ancira-Cortez A; Ramírez-Nava G; Santos-Cuevas C; Luna-Gutiérrez M; Ocampo-García B
Front Med (Lausanne); 2023; 10():1191315. PubMed ID: 37378300
[TBL] [Abstract][Full Text] [Related]
3. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors.
Escorcia FE; Houghton JL; Abdel-Atti D; Pereira PR; Cho A; Gutsche NT; Baidoo KE; Lewis JS
Theranostics; 2020; 10(1):151-165. PubMed ID: 31903112
[No Abstract] [Full Text] [Related]
4. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of
Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Luna-Gutiérrez M; Ramírez-Nava G; Ocampo-García B
Polymers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569625
[TBL] [Abstract][Full Text] [Related]
6. The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal.
Sarkhosh-Inanlou R; Imani M; Sam MR
Biomed Pharmacother; 2020 Dec; 132():110807. PubMed ID: 33068939
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.
Saur D; Seidler B; Schneider G; Algül H; Beck R; Senekowitsch-Schmidtke R; Schwaiger M; Schmid RM
Gastroenterology; 2005 Oct; 129(4):1237-50. PubMed ID: 16230077
[TBL] [Abstract][Full Text] [Related]
8. Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-κB signaling.
Wang J; Wang H; Cai J; Du S; Xin B; Wei W; Zhang T; Shen X
Exp Cell Res; 2018 Apr; 365(1):12-23. PubMed ID: 29453972
[TBL] [Abstract][Full Text] [Related]
9. Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.
Wu PF; Lu ZP; Cai BB; Tian L; Zou C; Jiang KR; Miao Y
Chin Med J (Engl); 2013; 126(17):3371-4. PubMed ID: 24033967
[TBL] [Abstract][Full Text] [Related]
10. Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer.
Min Y; Adachi Y; Yamamoto H; Ito H; Itoh F; Lee CT; Nadaf S; Carbone DP; Imai K
Cancer Res; 2003 Oct; 63(19):6432-41. PubMed ID: 14559833
[TBL] [Abstract][Full Text] [Related]
11. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
12. Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways.
Shen X; Artinyan A; Jackson D; Thomas RM; Lowy AM; Kim J
Pancreas; 2010 Jan; 39(1):81-7. PubMed ID: 19820417
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of CXCR4 and β-catenin in pancreatic cancer.
Wang Z; Ma Q; Li P; Sha H; Li X; Xu J
Anticancer Res; 2013 Sep; 33(9):4103-10. PubMed ID: 24023356
[TBL] [Abstract][Full Text] [Related]
14. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
15. The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer.
Sato N; Matsubayashi H; Fukushima N; Goggins M
Cancer Biol Ther; 2005 Jan; 4(1):70-6. PubMed ID: 15662133
[TBL] [Abstract][Full Text] [Related]
16.
Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy.
Sleightholm RL; Neilsen BK; Li J; Steele MM; Singh RK; Hollingsworth MA; Oupicky D
Pharmacol Ther; 2017 Nov; 179():158-170. PubMed ID: 28549596
[TBL] [Abstract][Full Text] [Related]
18. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
19. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
Aghevlian S; Lu Y; Winnik MA; Hedley DW; Reilly RM
Mol Pharm; 2018 Mar; 15(3):1150-1159. PubMed ID: 29314858
[TBL] [Abstract][Full Text] [Related]
20. PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.
Lee Y; Kim SJ; Park HD; Park EH; Huang SM; Jeon SB; Kim JM; Lim DS; Koh SS
Oncogene; 2010 Jan; 29(1):56-67. PubMed ID: 19784070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]